Medici List

Amalgamated Financial Corp. is a Delaware public benefit holding company for Amalgamated Bank that markets itself as "America’s Socially Responsible Bank," focused on impact banking, mission-aligned lending, trust and investment management, and ESG/climate finance.

Clinical-stage biotechnology company developing small-molecule and oligonucleotide therapeutics for liver diseases (HBV, MASH/obesity) and viral infections (pan-coronavirus), with in-house CMC and discovery capabilities and multiple pre-commercial Phase 2 programs.

CAMP4 Therapeutics is a clinical-stage biopharmaceutical company developing RNA-targeting antisense oligonucleotide therapies to upregulate gene expression for haploinsufficient CNS genetic diseases, with lead candidate CMP-002 for SYNGAP1-related developmental and epileptic encephalopathy.

Global medical device company specializing in treatments and devices for musculoskeletal pain and injury recovery across Pain Treatments, Surgical Solutions, and Restorative Therapies, with US and International reporting segments.

Blue Owl Capital Corporation II is a closed-end, externally managed business development company that primarily originates and invests in debt (with selective equity) in U.S. middle-market companies to generate current income and secondary capital appreciation.

CPI Card Group Inc. is a U.S.-focused payments technology company that provides end-to-end physical and digital payment card production, personalization, fulfillment and related secure services for financial institutions, processors, fintechs and prepaid program managers.

Atea Pharmaceuticals is a late-stage clinical biopharmaceutical company developing oral nucleos(t)ide-based antivirals—primarily the HCV regimen bemnifosbuvir+ruzasvir and HEV candidate AT-587—targeting single-stranded RNA viruses.

Clinical-stage biopharmaceutical company developing AD04 (ondansetron) for genotype-guided treatment of Alcohol Use Disorder, paired with a companion diagnostic.

Ambiq is a public fabless semiconductor company that designs ultra-low-power SoCs and supporting software using its SPOT sub-threshold/near-threshold platform for energy-efficient edge AI compute.

Externally managed, non‑diversified closed‑end business development company (BDC) focused on middle‑market lending and credit strategies (senior secured loans, mezzanine debt, selective equity, CLO exposure and joint ventures), advised by Sierra Crest Investment Management LLC (an affiliate of BC Partners).

Regional bank engaged in mortgage and consumer lending, investment securities management, and deposit/borrowing activities (includes loans held for sale, FHLB transactions, BOLI, and securitization-related items).

BioLargo, Inc. is a diversified cleantech company that invents, develops, and commercializes technologies for air quality, water treatment, long-duration energy storage, and medical wound care through subsidiaries, partnerships, licensing, joint ventures, and IP sales.